Studies on LRRK2 have extensively explored the toxic gain of function hypothesis for LRRK2 suggesting that expression of a disease mutant form of LRRK2 would lead, in cellular or in vivo models, to PD phenotypes, notably cell death, the presence of intracellular inclusions or loss of synaptic connections. Here, LRRK2 is linked to Parkinson disease.